IRVINE, Calif., Dec. 18, 2017 — Identillect Technologies Corp. (the “Company” or “Identillect”) (TSX-V:ID) (OTCQB:IDTLF) (Frankfurt:8ID), a leading provider of email security today, announced a joint project with QubeChain to provide Multi-Factor Authentication (“MFA”) with their Self-Sovereign ID (“SSI”) platform, an enhanced level of security for organizations at higher risk or with advanced security demands.
The utilization of weak passwords can render the most robust security system ineffective. The more sophisticated the password the more secure the system will be. According to a recent security intelligence article, “In 2016 10 million passwords were analyzed, over 5 million of those passwords were made up of the same 25 recurring words providing little confidence on password integrity.” The lack of originality with passwords is adversely affecting security. Of the passwords analyzed 17% of these passwords were “123456”.Rees Morgan, CEO of QubeChain stated, “We are excited to partner with Identillect in this multi-factor authentication project, continually achieving more advanced security protocols and providing superior products to bring to market. Combining a blockchain infrastructure with MFA advances the security and integrity of the information.”Identillect’s CEO Todd Sexton was quoted, “Identillect and QubeChain are achieving new levels of innovation in our product line. We are advancing security protocols while maintaining Identillect’s core belief that security should be simple. We’re excited about the prosperity of the relationship between QubeChain and Identillect and look forward to the development of additional projects to come.”Identillect’s continuous development with the goal of protecting our clientele’s data and information should lead to continuous growth in 2018. At the recent “Black Hat Conference”, an event held yearly for hackers, 250 hackers were surveyed, and they claimed their biggest obstacles were Multi-Factor Authentication and encryption. In an article by Risk Control Strategies the growth rate for MFA is said to see an annual growth rate of nearly 19% by the year 2022.About QubeChain LLCQubeChain LLC is built to foster transformation by leveraging creative innovation and deep industry expertise to produce Applied Uses of BLOCKCHAIN TECHNOLOGY across all industries. Founded in 2015, QubeChain has aligned with industry leaders in targeted verticals to create product offerings that use blockchain technology to solve actual pain points, including QUBEPAY, a B2B Supplier Enablement Payment Processing Suite for merchant retailers (i.e. Home Depot). Similarly, QubeChain is using blockchain to build a bridge between commercial healthcare systems and the patient, including a blockchain-enabled eHealth Exchange “use case” for the Military Health System (MHS) to allow secure, permissioned, mobile access to Patient Health Information.QubeChain LLC foresees imminent blockchain disruption for most, if not all, value-exchange delivery systems. It expects rapid growth on the strength of its various resources and relationships as well as the focus of its management team. Please visit www.QubeChain.com to learn more about Qubechain’s products and services.About IdentillectIdentillect Technologies is the leading provider of email encryption service Delivery Trust®, empowering enterprises of all sizes to protect their business and their client’s critical information against cyber security attacks. Delivery Trust® is an award-winning, multi-platform plug-in, which gives users complete control of their emails, for one low price. One simple integration complies with all regulations and most importantly provides peace of mind. For more information, or your free trial, please visit www.identillect.com.On Behalf of the Board of Directors of:IDENTILLECT TECHNOLOGIES CORP.Todd Sexton
Chief Executive Officer
Tel: (949) 468-7878
Email: [email protected]Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward-looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.
Latest posts by Brad Bennett (see all)
- MediciNova Announces Upcoming Presentation of the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive MS at the American Academy of Neurology (AAN) 70th Annual Meeting in Los Angeles, California - February 18, 2018
- Mario Lopez Announced As Host To The 'Splash of Love' Gala Fundraiser At Proud Bird Food Bazaar & Events Center - February 18, 2018
- Oxnard Teen, Skilled Boxer Honored as BGCOP's Youth of the Year - February 18, 2018